Results 81 to 90 of about 15,444 (261)
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America [PDF]
, 2017 Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America.
Andes, David +13 more
core
Pharmacoepidemiology and Drug Safety, Volume 34, Issue 9, September 2025.ABSTRACT Purpose Owing to their rapid antipyretic effects and predictable pharmacokinetic properties, acetaminophen (AAP) are commonly administered intravenously to severely ill patients. However, the potential development of hypotension as a consequence of intravenous AAP administration has not been thoroughly addressed.
Yu‐Ri Choi +6 more
wiley +1 more source
Çocuklarda Mikafungin Kullanımının Değerlendirilmesi
Mikrobiyoloji Bulteni, 2020 Micafungin is recommended especially in patients with liver and kidney failure and in the presence of other side effects due to antifungals apart from its known priority indications such as invasive candidiasis. The aim of this study was to evaluate the children who have received micafungin treatment. In the study, 125 children who were hospitalized in
Edanur Yeşil +14 more
openaire +4 more sources
International Journal of Infectious Diseases, 2020 Objectives: The D-index is defined as the area over the neutrophil curve during neutropenia. The CEDMIC trial confirmed the noninferiority of D-index-guided early antifungal therapy (DET) using micafungin to empirical antifungal therapy (EAT).
Shun-ichi Kimura +18 more
doaj +1 more source
Comparative population plasma and tissue pharmacokinetics of micafungin in critically ill patients with severe burn injuries and patients with complicated intra-abdominal infection [PDF]
, 2016 Severely burned patients have altered drug pharmacokinetics (PKs), but it is unclear how different they are from those in other critically ill patient groups.
Agrifoglio, A. +8 more
core +2 more sources
Ibrexafungerp: Mechanism of Action, Clinical, and Translational Science
Clinical and Translational Science, Volume 18, Issue 9, September 2025.ABSTRACT Ibrexafungerp is a first‐in‐class triterpenoid antifungal that targets β‐(1,3)‐glucan synthase in fungal cell wall development. It is indicated for vulvovaginal candidiasis (VVC) and recurrent vulvovaginal candidiasis (RVVC) in adult and post‐menarchal pediatric females.
Adelynne H. Walley +3 more
wiley +1 more source
Micafungin in the treatment of candiduria: A case series
Medical Mycology Case Reports, 2016 Echinocandin antifungal agents are not routinely recommended for the treatment of candiduria due to low urine concentrations and a paucity of clinical data supporting this indication. This report presents five cases describing the use of micafungin for the treatment of candiduria.
Katie M. Muzevich, Lauren E. Kane
openaire +4 more sources
Extended Survival in a Dog With Disseminated Protothecosis
Journal of Veterinary Internal Medicine, Volume 39, Issue 5, September/October 2025.ABSTRACT A 5‐year‐old Basenji Mix achieved extended survival with treatment for disseminated protothecosis. The dog originally presented with iridal hyperemia and ocular ultrasonographic examination revealed a mass effect. Histopathology revealed ocular protothecosis and staging confirmed disseminated protothecosis.
Bianca G. Landfield +5 more
wiley +1 more source
The seizure of illicit assets: patterns of civil forfeiture in Canada and Ireland [PDF]
, 2013 No description ...
Gallant, M Michelle, King, Colin
core +1 more source
The activity of micafungin against clinical isolates of non-albicans Candida spp.
Current Issues in Pharmacy and Medical Sciences, 2015 Infections caused by non-albicans Candida spp. are an important medical problem in people from risk groups, e.g. hematooncological patients. The aim of this paper was to analyse the in vitro activity of micafungin against 30 clinical isolates of non ...
Biernasiuk Anna +3 more
doaj +1 more source